Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis

Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis

(2010) G. T. EVERSON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma

(2010) Ju Dong Yang et al.   Clinical Gastroenterology and Hepatology

Factors That Determine the Development and Progression of Gastroesophageal Varices in Patients With Chronic Hepatitis C

(2010) Robert J. Fontana et al.   GASTROENTEROLOGY

Outcome of sustained virological responders with histologically advanced chronic hepatitis C

(2010) Timothy R. Morgan et al.   HEPATOLOGY

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

(2010) Paul Y Kwo et al.   LANCET

Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis

(2010) Kausik Das et al.   LIVER INTERNATIONAL

Telaprevir for Previously Treated Chronic HCV Infection

(2010) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis

(2010) Ryota Masuzaki et al.   ONCOLOGY

Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study

(2009) Savino Bruno et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hepatitis B Virus Load in Serum Does Not Reflect Histologic Activity in Patients With Decompensated Cirrhosis

(2009) Jin Dong Kim et al.   Clinical Gastroenterology and Hepatology

Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial

(2009) Mitchell L. Shiffman et al.   GASTROENTEROLOGY

Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

(2009) Bruce R. Bacon et al.   HEPATOLOGY

Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis

(2009) Ju Hyun Shim et al.   JOURNAL OF HEPATOLOGY

Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension

(2009) E. G. Giannini et al.   JOURNAL OF INTERNAL MEDICINE

Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure

(2009) Fabien Zoulim et al.   LIVER INTERNATIONAL

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis

(2008) Tomohiro Nishida et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study

(2008) Jose A. Carrión et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C

(2008) T.-M. Scherzer et al.   JOURNAL OF VIRAL HEPATITIS

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

(2008) Adrian M. Di Bisceglie et al.   NEW ENGLAND JOURNAL OF MEDICINE